London, Glasgow UK, Tuesday 17 July 2007 – Cancer Research Technology Limited (CRT), the oncology-focused development and commercialisation company and The Beatson Institute for Cancer Research, Glasgow (Beatson Institute) today announce a new research collaboration with AstraZeneca to develop optical imaging techniques for use in cancer research.
